SCHEMBL40101

SCHEMBL40101

CCCCCCC(=O)CCCCCCCCCCC(=O)OC

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.59
KMT2A Q03164 1/20 0.59
TSHR P16473 3/20 0.58
DGKA P23743 1/20 0.57
POLB P06746 1/20 0.56
POLA1 P09884 1/20 0.56
LMNA P02545 3/20 0.53
HAO1 Q9UJM8 1/20 0.53
CA12 O43570 1/20 0.53
CA2 P00918 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
PAM P19021 2/20 0.52
ALDH1A1 P00352 1/20 0.52
EPHX2 P34913 1/20 0.51
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
KDM5A P29375 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31190487 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL12192678 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL6415465 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL16046101 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL3033282 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL20637044 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL7112187 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL3621835 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL19816815 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB
SCHEMBL15689621 1.00 MAPT (0.59) MAPTKMT2ATSHRDGKAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4069163-A PARTIAL PHOSPHOROUS PENTASULFIDE ADDUCT OF A POLYCYANOETHYLATED KETO FATTY ESTER AS OIL ADDITIVE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-01-17 US claimed
EP-4703345-A1 A PROCESS FOR THE SELECTIVE DEOXYGENATION OF CARBOXYLIC ACIDS OR DERIVATIVES THEREOF Universität Konstanz (DE) 2026-03-04 EP disclosed
EP-3645503-B1 PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS VITAWORKS IP LLC (US) 2025-10-15 EP disclosed
EP-3645505-B1 PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS VITAWORKS IP LLC (US) 2024-05-29 EP disclosed
US-20240084343-A1 METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION KIVERDI INC (US) 2024-03-14 US disclosed
EP-3645499-B1 PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS VITAWORKS IP LLC (US) 2024-03-13 EP disclosed
EP-3645504-B1 PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS VITAWORKS IP LLC (US) 2024-03-06 EP disclosed
EP-3645502-B1 PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS VITAWORKS IP LLC (US) 2023-08-23 EP disclosed
EP-3652149-B1 PROCESS FOR PRODUCING LONG CHAIN ACIDS AND DIBASIC ACIDS VITAWORKS IP LLC (US) 2022-12-28 EP disclosed
CN-110770205-B Production process of long-chain amino acid and dibasic acid 维生源知识产权有限责任公司 2022-11-18 CN disclosed
WO-2013013990-A1 PROCESS FOR THE ISOMERISATION OF SUBSTITUTED ALKENES DSM IP ASSETS B.V. (NL) 2013-01-31 WO disclosed
WO-2011163434-A1 PURIFIED ACETYLATED DERIVATIVES OF CASTOR OIL AND COMPOSITIONS INCLUDING SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2011-12-29 WO disclosed
US-20110076502-A1 PURIFIED ACETYLATED DERIVATIVES OF CASTOR OIL AND COMPOSTIONS INCLUDING SAME DOW GLOBAL TECHNOLOGIES LLC 2011-03-31 US disclosed
WO-1998034943-A1 SURFACTANT AMINES AND GLYCOSIDES INSTITUUT VOOR AGROTECHNILOGISCH ONDERZOEK (ATO-DLO) (NL) 1998-08-13 WO disclosed
EP-0818431-A1 Scavenger assisted combinatorial process for preparing libaries of secondary amine compounds ELI LILLY AND COMPANY (US) 1998-01-14 EP disclosed
WO-1997011046-A1 METHOD FOR THE OXIDATION OF ALCOHOLS INSTITUUT VOOR AGROTECHNOLOGISCH ONDERZOEK (ATO-DLO) (NL) 1997-03-27 WO disclosed
EP-0469041-A1 A PROCESS FOR ISOMERIZING OLEFINICALLY UNSATURATED SECONDARY ALCOHOLS HENKEL RESEARCH CORPORATION (US) 1992-02-05 EP disclosed
US-5019297-A Catalysis with hydrogenated palladium HENKEL RESEARCH CORPORATION (US) 1991-05-28 US disclosed
WO-1990012859-A1 A PROCESS FOR ISOMERIZING OLEFINICALLY UNSATURATED SECONDARY ALCOHOLS HENKEL RESEARCH CORPORATION (US) 1990-11-01 WO disclosed
US-4069163-A PARTIAL PHOSPHOROUS PENTASULFIDE ADDUCT OF A POLYCYANOETHYLATED KETO FATTY ESTER AS OIL ADDITIVE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076502-A1 PURIFIED ACETYLATED DERIVATIVES OF CASTOR OIL AND COMPOSTIONS INCLUDING SAME ACACA, ACAT2, ACACB MAPT 756/4885KMT2A 472/4885TSHR 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.